Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
13734-38-8
1807503-91-8
1807540-85-7
2055023-35-1
2055042-61-8
1623791-69-4 | Carboxy-peg4-phosphonic acid | AA019E56 | MFCD30182021
2112731-81-2 | N-(Azido-PEG2)-N-bis(PEG4-t-butyl ester) | AA019E9L | MFCD30723228
1632372-86-1 | Azido-PEG4-alpha-D- mannose | AA019EDY | MFCD31692217
107276-46-0 | N-(2,5-Diethoxyphenyl)-4-methyl-benzenesulfonamide | AA019EHW | MFCD10170348
5998-92-5 | 2-(Pyridin-4-yl)oxazole | AA019EKL | MFCD00956160
146575-56-6 | 2-(Dimethoxymethyl)-2-methylchroman-4-one | AA019ENO | MFCD30185767
1250998-27-6 | Tert-Butyl Hexahydro-1H-3A,7-Epoxypyrrolo[3,4-C]Azepine-5(4H)-Carboxylate | AA019EQW | MFCD17016829
1240301-71-6 | N'-hydroxy-2,2-dimethylpropanimidamide | AA019ETV | MFCD06200902
701933-54-2 | 4-bromo-N-(2,6-difluorophenyl)benzenesulfonamide | AA019EXH | MFCD04402513
79-57-2 | Oxytetracycline | AA019FPP | MFCD00003700